Veradace Partners Sends Letter to Tiptree Shareholders About the Proposed Fortegra Sale to DB Insurance
Veradace's Opposition to Tiptree's Proposed Sale: Veradace Partners L.P., a significant shareholder of Tiptree Inc., is urging fellow shareholders to vote against the proposed sale of Fortegra Group to DB Insurance, claiming the transaction is structured to benefit Tiptree management at the expense of shareholders.
Concerns Over Transaction Structure: The proposed asset sale is criticized for being tax-inefficient and potentially allowing Tiptree management to access nearly $1 billion of shareholder funds without delivering adequate returns to shareholders.
Performance of Fortegra: Veradace highlights Fortegra's strong financial performance, including significant growth in adjusted net income, and argues that shareholders would be better off without the deal, as it undervalues the asset.
Call for Restructuring the Deal: Veradace suggests that if DB Insurance wishes to acquire Fortegra, it should do so through a direct acquisition of Tiptree shares at $28.75 per share, ensuring that shareholders receive fair value.
Trade with 70% Backtested Accuracy
Analyst Views on TIPT
About TIPT
About the author

Tiptree Shareholders Approve Merger Agreement with Fortegra
- Merger Approval: At the Special Meeting, approximately 81% of Tiptree shareholders voted in favor of the merger agreement with Fortegra and DB Insurance, marking a significant milestone in Tiptree's value creation and expected to enhance long-term shareholder value.
- Clear Transaction Structure: The merger will be executed through a wholly owned subsidiary of DB merging with Fortegra, ensuring a smooth transaction process and simplifying subsequent integration efforts.
- Expected Completion Timeline: Tiptree anticipates closing the merger in mid-2026, subject to customary closing conditions including necessary regulatory approvals, which will lay a foundation for future growth.
- Commitment to Transparency: Tiptree will file a Form 8-K with the SEC to report the final voting results from the Special Meeting, demonstrating the company's commitment to shareholder transparency and compliance.

Veradace Urges Tiptree Shareholders to Vote Against Fortegra Sale
- Shareholder Opposition: Veradace Partners L.P., holding 5.1% of Tiptree Inc., urges shareholders to vote against the proposed sale of Fortegra to DB Insurance at the special meeting on December 3, 2025. This proposal is viewed as a rushed deal that overlooked superior alternatives.
- Management Conflicts of Interest: Glass Lewis and Egan-Jones highlight that the deal structure raises questions about management incentives, potentially allowing management to continue siphoning value from shareholders instead of providing immediate payouts. This structure places nearly $1 billion in proceeds without a clear capital return plan, increasing shareholder risk.
- Negative Market Reaction: Following the announcement of the transaction, Tiptree's stock price dropped over 20%, indicating a lack of confidence from the market regarding the deal. Egan-Jones also noted that the deal leaves Tiptree with nearly $1 billion in unallocated cash, giving management discretion to redeploy capital at will.
- Allegations of Analytical Errors: Veradace claims that Institutional Shareholder Services' analysis contains several material errors, failing to fully assess the deal's valuation and potential risks. The conclusions drawn are seen as based on irrelevant factors, neglecting the long-term value implications for shareholders.






